QC
MRNA icon

Quantessence Capital’s Moderna MRNA Stock Holding History

Quantessence Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,063
Closed -$206K – 111
2026
Q1 		$206K Buy
+4,063
New +$190K 1.01% 47
2025
Q2 		– Sell
-31,821
Closed -$902K – 354
2025
Q1 		$902K Sell
31,821
-12,686
-29% -$450K 0.23% 133
2024
Q4 		$1.85M Buy
+44,507
New +$2.13M 0.76% 33

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Quantessence Capital's MRNA Position: Q2 2026 in Review

Quantessence Capital sold out of Moderna (MRNA) in Q2 2026, closing a stake of 4,063 shares — an estimated $206K sold.

Quantessence Capital first reported a position in MRNA in Q4 2024 and held it in 3 quarters. The position peaked at $1.85M in Q4 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Quantessence Capital reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Quantessence Capital sold 4,063 Moderna shares in Q2 2026, an estimated $206K.
  • Quantessence Capital first reported a position in Moderna in Q4 2024 and held it in 3 quarters.
  • Quantessence Capital's Moderna position peaked at $1.85M in Q4 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Quantessence Capital's 13F filing for Q2 2026, filed 14 Aug 2026.